Treating childhood cancer worldwide
…area. Thanks to support from the American Society of Hematology, he came to DF/CHCC in December to observe hospital rounds and to attend the annual hematology meeting. In May he’s…
…area. Thanks to support from the American Society of Hematology, he came to DF/CHCC in December to observe hospital rounds and to attend the annual hematology meeting. In May he’s…
…mother. “The port did help.” Vijay Sankaran, MD, PhD, in the hematology program of the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, checks Jack’s vitals. They discuss another of Jack’s…
…into their cells to correct errors in their DNA. Williams, who is chief of the Division of Hematology/Oncology and director of Translational Research at Boston Children’s Hospital, as well as…
…away. She went to her primary care doctor, who referred her to the BWH Hematology Department. Blood tests there revealed the source of Keener’s symptoms: aplastic anemia and paroxysmal nocturnal…
…Cells Benign blood disorders such as anemia and sickle cell disease are often treated at cancer centers because such institutions are home to experts in hematology, which is a branch…
…Pediatric Hematology/Oncology, identified a set of critical dependency genes in MYCN-amplified neuroblastoma that are essential for cell state and survival in the tumor. “By collaborating, we can quickly move from…
…of Hematology/Oncology and director of Clinical and Translational Research at Boston Children’s Hospital and associate chair of Pediatric Oncology at Dana-Farber. “We’re increasingly understanding how cancer tones down the immune…
…part of the leukemia is often resistant to one protocol or the other,” explains Steven Margossian, MD, PhD, a senior physician of pediatric hematology and oncology at Dana-Farber/Boston Children’s Cancer…
…spread by massage,” says Ann LaCasce, MD, MMSc, a physician in the Adult Lymphoma Program at Dana-Farber and director of the Dana-Farber/Partners CancerCare Fellowship Program in Hematology/Medical Oncology. So, What…
…Journal of Medicine on the safety and efficacy of mitapivat, an oral drug developed by Agios Pharmaceuticals, Inc., of Cambridge, Mass. Grace, who is the director of the hematology clinic…
Joe Yannetty earns a living making people laugh, so when it came to thanking his caregivers at Dana-Farber/New Hampshire Oncology-Hematology (DF/NHOH) for the successful treatment of his throat cancer, candy…
…Tufts University School of Medicine, securing a scholarship through the Air Force Health Professions Scholarship Program (HPSP). After post-graduate training in internal medicine, medical oncology, and hematology, McGregor began his…
…(middle), with his son, Tripp, and Dana-Farber President and CEO Laurie H. Glimcher, MD. HMS Dean Daley, who works in the field of hematology, called Kaelin “the consummate physician-scientist, the…
…Board of Trustees of Boston Children’s Hospital, was senior author on the paper. The study was funded by the National Institutes of Health (DK06834813, HL032262-25) and the American Society of Hematology….
…American Journal of Hematology. First author is Jennifer R. Brown, MD, PhD, director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber. He says the drug, which…
…been shown to be superior to the targeted therapy, rituximab, according to Ann LaCasce, MD, MMSc, a medical oncologist specializing in lymphoma and director of the Dana-Farber/Partners CancerCare Hematology-Medical Oncology…
…in Hematology/Medical Oncology. “We do not think of lymphoma as a disease that metastasizes – rather, it is often a systemic disease that travels through the lymphatics and blood and…
…of Hematology. Bustoros and his colleagues are genetically analyzing bone marrow and blood samples from nearly two hundred people with SMM. For many of these individuals, two sets of samples…
…in Hematology/Medical Oncology. What are the treatment options for patients with refractory disease? When a patient’s disease is or becomes refractory, the next step may be to try another form…
…three-drug RVd regimen. In a report to the American Society of Hematology in 2019 and updated in a full publication of Blood this year, investigators demonstrated that the addition of…